Total Funding
51
66
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
38880
Teknova is a biotechnology company that offers DNA sequencing, clone testing and clone-based crop research services.
Acquired by 
Telegraph Hill Partners
Bob McNamara: Board Member, Chair of Audit Committee, Member Compensation CommitteePast Role: LDR Holding, Executive Vice President, Chief Financial Officer
Ted Davis: CEO & Founder
About the Company
Teknova provides critical reagents for bioprocessing, bioproduction, and molecular diagnostics. We support customers in the research, clinical, and applied markets with standard catalog offerings and custom GMP products, including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents.
Focusing on agility and customer satisfaction, we strive to meet complex formulation and packaging requirements as well as provide fast turnaround for custom GMP products. As a partner to the biopharma sector, our R&D team offers expertise from prototype product design to guidance on GMP manufacturing of media, buffers, and reagents for the entire cell and gene therapy production workflow.
